For comments, suggestions
Created with Raphaël 2.1.0 07.09.2022 Formal examination (assignment of filing date) 28.09.2022 Preliminary examination 26.10.2022 Establishment of the national regular filing 26.10.2022 Examination of the conditions for granting STPI 31.03.2023 Publication of the decision of grant (Y) 30.09.2023 Completion of the opposition filing period 31.10.2023 Issuance of patent (Z) 18.05.2024 07.09.2027 Valid until 07.09.2028 Patent expiration date

Patent in force


(11)Number of the document1677
(21)Number of the applications 2022 0057
(22)Filing date of the application2022.09.07
(71)Name(s) of applicant(s), code of the countryINSTITUTIA MEDICO-SANITAR PUBLICA INSTITUTUL ONCOLOGIC, MD;
(72)Name(s) of inventor(s), code of the countryTRIPAC Irina, MD; STRATAN Valentina, MD; SITNIC Victor, MD; TUTUIANU Valeriu, MD; POPA Cristina, MD;
(73)Name(s) of owner(s), code of the countryINSTITUTIA MEDICO-SANITAR PUBLICA INSTITUTUL ONCOLOGIC, MD;
(54)Title of the inventionMethod for predicting the course of stage I-II endometrial cancer
(13)Kind-of-document code
Z, BOPI 10/2023
Y, BOPI 03/2023
(51)International Patent Classification A61B 10/00 (2006.01); C12Q 1/6806 (2018.01); C12Q 1/6886 (2018.01);
(19)CountryMD
(45)Date of publication of patent granting decision:2023.03.31
(47)Date of issuance of patent2023.10.31
 Substantive examiner(s)GROSU Petru
 Payment for maintenance up to the date2027.09.07
Up
/inventions/details/s 2022 0057